Updated

India’s Adani Wilmar sees Q3 sales growth in high single digits

BENGALURU (Reuters) -Fast-moving consumer goods firm Adani Wilmar Ltd said on Tuesday its sales would grow in high single digits in the third quarter, helped by strong demand during the festive season and stronger out-of-home consumption. Standalone sales volume will grow in high teens, the company said in a regulatory filing. Price volatility in its …

India’s Adani Wilmar sees Q3 sales growth in high single digits Read More »

Oil edges higher as petroleum demand set to touch record next year

By Arathy Somasekhar HOUSTON (Reuters) – Oil prices edged slightly higher on Tuesday as the U.S. government forecast record global petroleum consumption next year and as the dollar hovered at seven-month lows. Global consumption of liquid fuels is forecast to reach 102.2 million barrels per day in 2024, driven primarily by growth in countries like …

Oil edges higher as petroleum demand set to touch record next year Read More »

Stocks rise, bond yields rise with December’s upcoming price data in focus

By Sinéad Carew and Amanda Cooper NEW YORK, LONDON (Reuters) – Wall Street’s major stock averages closed higher on Tuesday, steadying in the afternoon after early volatility while Treasury yields rose as investors waited anxiously for U.S. inflation data due later in the week. The U.S. dollar was little changed versus the euro and othermajor …

Stocks rise, bond yields rise with December’s upcoming price data in focus Read More »

Brazil’s 2022 inflation slows sharply, misses government target

By Marcela Ayres BRASILIA (Reuters) -Brazil’s inflation ended 2022 with a sharp slowdown from double-digit peaks seen throughout the year on the back of fiscal measures and an aggressive monetary policy tightening, but once again missed the government’s official target. The benchmark IPCA consumer price index rose 5.79% last year, statistics agency IBGE said on …

Brazil’s 2022 inflation slows sharply, misses government target Read More »

Merck COVID treatment priced at 1,500 yuan per bottle in China’s Tianjin

BEIJING (Reuters) -Merck & Co’s COVID-19 antiviral treatment molnupiravir was priced at 1,500 yuan ($221.21) per bottle in Tianjin, according to the northern Chinese city’s medical purchasing centre on Tuesday. Each bottle contains 40 pills – enough for one course of treatment – according to the centre. The treatment, which is sold under the brand …

Merck COVID treatment priced at 1,500 yuan per bottle in China’s Tianjin Read More »